23 related articles for article (PubMed ID: 31170959)
1. miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response.
Cataldo A; Cheung DG; Balsari A; Tagliabue E; Coppola V; Iorio MV; Palmieri D; Croce CM
Oncotarget; 2016 Jan; 7(1):786-97. PubMed ID: 26623722
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic Landscape of Cisplatin-Resistant Neuroblastoma Cells.
Rodrigo MAM; Buchtelova H; Jimenez AMJ; Adam P; Babula P; Heger Z; Adam V
Cells; 2019 Mar; 8(3):. PubMed ID: 30871063
[TBL] [Abstract][Full Text] [Related]
3. ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo.
Yu Y; Zhao Y; Choi J; Shi Z; Guo L; Elizarraras J; Gu A; Cheng F; Pei Y; Lu D; Fabbri M; Agarwal S; Zhang C; Jung SY; Foster JH; Yang J
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428626
[TBL] [Abstract][Full Text] [Related]
4. FOXF2 Regulates PRUNE2 Transcription in the Pathogenesis of Colorectal Cancer.
Li T; Huang S; Yan W; Zhang Y; Guo Q
Technol Cancer Res Treat; 2022; 21():15330338221118717. PubMed ID: 35929169
[No Abstract] [Full Text] [Related]
5. PRUNE2 inhibits progression of colorectal cancer
Li T; Huang S; Yan W; Zhang Y; Guo Q
Exp Ther Med; 2022 Feb; 23(2):169. PubMed ID: 35069850
[TBL] [Abstract][Full Text] [Related]
6. The c-Rel transcription factor limits early interferon and neuroinflammatory responses to prevent herpes simplex encephalitis onset in mice.
Mancini M; Charbonneau B; Langlais D; Vidal SM
Sci Rep; 2021 Oct; 11(1):21171. PubMed ID: 34707143
[TBL] [Abstract][Full Text] [Related]
7. The Jieduan-Niwan (JDNW) Formula Ameliorates Hepatocyte Apoptosis: A Study of the Inhibition of E2F1-Mediated Apoptosis Signaling Pathways in Acute-on-Chronic Liver Failure (ACLF) Using Rats.
Hou W; Hao Y; Yang W; Tian T; Fang P; Du Y; Gao L; Gao Y; Zhang Q
Drug Des Devel Ther; 2021; 15():3845-3862. PubMed ID: 34526765
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ataxia telangiectasia-p53-E2F-1 pathway in neurons as a target for the prevention of neuronal apoptosis.
Camins A; Verdaguer E; Folch J; Beas-Zarate C; Canudas AM; Pallàs M
Curr Drug Metab; 2007 Oct; 8(7):709-15. PubMed ID: 17979659
[TBL] [Abstract][Full Text] [Related]
9. Programmed expression of pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in neuroblastoma cells.
Islam MS; Takano R; Yokochi T; Akter J; Nakamura Y; Nakagawara A; Tatsumi Y
BMC Cancer; 2019 Jun; 19(1):542. PubMed ID: 31170959
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of BMCC1 mediated by E2F1 in neuroblastoma cells.
Islam MS; Tatsumi Y; Takano R; Yokochi T; Akter J; Ozaki T; Nakamura Y; Ohira M; Nakagawara A
Biochem Biophys Res Commun; 2016 Sep; 478(1):81-86. PubMed ID: 27453342
[TBL] [Abstract][Full Text] [Related]
11. BMCC1, which is an interacting partner of BCL2, attenuates AKT activity, accompanied by apoptosis.
Tatsumi Y; Takano R; Islam MS; Yokochi T; Itami M; Nakamura Y; Nakagawara A
Cell Death Dis; 2015 Jan; 6(1):e1607. PubMed ID: 25611382
[TBL] [Abstract][Full Text] [Related]
12. Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells.
Ando K; Nakamura Y; Nagase H; Nakagawara A; Koshinaga T; Wada S; Makishima M
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362335
[TBL] [Abstract][Full Text] [Related]
13. Novel 1p tumour suppressor Dnmt1-associated protein 1 regulates MYCN/ataxia telangiectasia mutated/p53 pathway.
Yamaguchi Y; Takenobu H; Ohira M; Nakazawa A; Yoshida S; Akita N; Shimozato O; Iwama A; Nakagawara A; Kamijo T
Eur J Cancer; 2014 May; 50(8):1555-65. PubMed ID: 24559687
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas.
Machida T; Fujita T; Ooo ML; Ohira M; Isogai E; Mihara M; Hirato J; Tomotsune D; Hirata T; Fujimori M; Adachi W; Nakagawara A
Oncogene; 2006 Mar; 25(13):1931-42. PubMed ID: 16288218
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
